Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Droz

Showing results (721-730 of 1,239) with videos related to

Pageof 124
Sort By:
Journal of Surgical Oncology|March 1, 1996
Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumorsS Culine, C Theodore, F Farhat, et al.
Lancet (London, England)|April 7, 1990
Anti-glomerular-basement-membrane disease after lithotripsyV Guerin, C Rabian, L H Noel, et al.
Journal of Biological Response Modifiers|December 1, 1990
Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinomaT Hercend, F Farace, D Baume, et al.
Inorganic Chemistry|April 23, 2013
A polyaromatic terdentate binding unit with fused 5,6-membered chelates for complexing s-, p-, d-, and f-block cationsThi Nhu Y Hoang, Marie Humbert-Droz, Thibault Dutronc, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 1, 2014
Intrapartum detection of Group B streptococci colonization by rapid PCR-test on labor wardMartin Mueller, Ariane Henle, Sara Droz, et al.
Bulletin Du Cancer|January 1, 1988
Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicityM Ghosn, P Carde, B Leclerq, et al.
American Journal of Clinical Oncology|April 1, 1997
Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumorsS Culine, C Théodore, M Bekradda, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|February 8, 1983
[Chemotherapy of Hodgkin disease with modified MOPP]J L Amiel, M Spielmann, P Kerbrat, et al.
Annales De Medecine Interne|October 1, 1978
[Rosai and Dorfman's syndrome]J L Amiel, R Gérard-Marchant, B Caillou, et al.
International Archives of Occupational and Environmental Health|February 1, 1982
1,1,1-Trichloroethane exposure, biologic monitoring by breath and urine analysesJ R Caperos, P O Droz, C L Hake, et al.
Pageof 124

Showing results (721-730 of 1,239) with videos related to

Sort By:
Pageof 124
Journal of Surgical Oncology|March 1, 1996
Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumorsS Culine, C Theodore, F Farhat, et al.
Lancet (London, England)|April 7, 1990
Anti-glomerular-basement-membrane disease after lithotripsyV Guerin, C Rabian, L H Noel, et al.
Journal of Biological Response Modifiers|December 1, 1990
Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinomaT Hercend, F Farace, D Baume, et al.
Inorganic Chemistry|April 23, 2013
A polyaromatic terdentate binding unit with fused 5,6-membered chelates for complexing s-, p-, d-, and f-block cationsThi Nhu Y Hoang, Marie Humbert-Droz, Thibault Dutronc, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 1, 2014
Intrapartum detection of Group B streptococci colonization by rapid PCR-test on labor wardMartin Mueller, Ariane Henle, Sara Droz, et al.
Bulletin Du Cancer|January 1, 1988
Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicityM Ghosn, P Carde, B Leclerq, et al.
American Journal of Clinical Oncology|April 1, 1997
Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumorsS Culine, C Théodore, M Bekradda, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|February 8, 1983
[Chemotherapy of Hodgkin disease with modified MOPP]J L Amiel, M Spielmann, P Kerbrat, et al.
Annales De Medecine Interne|October 1, 1978
[Rosai and Dorfman's syndrome]J L Amiel, R Gérard-Marchant, B Caillou, et al.
International Archives of Occupational and Environmental Health|February 1, 1982
1,1,1-Trichloroethane exposure, biologic monitoring by breath and urine analysesJ R Caperos, P O Droz, C L Hake, et al.
Pageof 124